Komori
Yamano Holdings (7571) · RiskOwnership status changed following the sale of listed shares

Market Price Risk on Investment Securities

First written in FY2019. 8 of 19 entries say "Worsened", first in FY2020. Latest entry: FY2026.

19entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2020-Q1 – FY2020WorsenedFY2022-Q1 – FY2022MitigatedFY2023-Q1 – FY2023WorsenedFY2024-Q2 – FY20252019: 320192020: 220202021: 420212022: 420222023: 220232024: 220242025: 120252026: 12026
Same theme, other companies
Market price fluctuation risk of financial instruments heldA theme 316 companies write about · 315 as a headwind · 2 as a tailwind

The whole theme swung hardest in 2019: 53 of 135 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 319 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026Ownership status changed following the sale of listed sharesAnnual report

    「Unlisted shares (amount recorded on the consolidated balance sheet: ¥34.810 million) are not disclosed because they are shares and other securities without a quoted market price.」

    Listed shares recorded at ¥87.165 million in the previous fiscal year were sold for ¥76.308 million in the current fiscal year, and a loss on sale of ¥5.045 million was recognized. At the end of the current fiscal year, investment securities consisted solely of unlisted shares without a quoted market price.
  2. FY2025MaterialisedAnnual report

    「During the consolidated fiscal year, an impairment loss of ¥81.354 million was recognized on securities (shares classified as available-for-sale securities: ¥81.354 million).」

    The risk of fluctuations in the market prices of investment securities materialized as a valuation loss and impairment loss of ¥81.354 million.
  3. FY2025-H1WorsenedAnnual report

    「Valuation difference on available-for-sale securities △¥7.580 million」

    The valuation difference on available-for-sale securities decreased by ¥7.580 million in the interim period, and the negative impact of market price fluctuations on net assets continued.
  4. FY2024-Q3WorsenedAnnual report

    「Other comprehensive income Valuation difference on available-for-sale securities △¥12.615 million」

    The valuation difference on available-for-sale securities decreased by ¥12.615 million in the cumulative first three quarters, and the negative impact of fluctuations in the market prices of investment securities on net assets emerged.
  5. FY2024-Q2WorsenedAnnual report

    「Valuation difference on available-for-sale securities △¥6.266 million」

    The valuation difference on available-for-sale securities decreased by ¥6.266 million in the first half, and the negative impact of market price fluctuations on net assets reappeared.
  6. FY2023MitigatedAnnual report

    「The valuation difference on available-for-sale securities changed from negative ¥55.601 million to negative ¥28.418 million, representing an increase of ¥27.183 million during the consolidated fiscal year.」

    The valuation difference on available-for-sale securities increased by ¥27 million, improving the impact of market price fluctuations on net assets from the ¥40 million decrease in the previous fiscal year.
  7. FY2023-Q2MitigatedAnnual report

    「Valuation difference on available-for-sale securities ¥17.279 million」

    The valuation difference on available-for-sale securities increased by ¥17.279 million, indicating an improvement in the negative impact of market price fluctuations from the end of the previous fiscal year.
  8. FY2023-Q1MitigatedAnnual report

    「Other comprehensive income Valuation difference on available-for-sale securities △¥1.906 million」

    The valuation difference on available-for-sale securities decreased by ¥1.906 million, although the decrease was smaller than the ¥17.137 million decrease in the same period of the previous year.
  9. FY2022WorsenedAnnual report

    「The valuation difference on available-for-sale securities increased by ¥43.705 million, while an impairment loss of ¥3.853 million was recognized on securities during the consolidated fiscal year.」

    In the current fiscal year, the valuation difference shifted from an increase in the previous fiscal year to a decrease, and the valuation difference on available-for-sale securities included in net assets decreased by ¥40.150 million.
  10. FY2022-Q3WorsenedAnnual report

    「This was attributable to a ¥95 million increase in share capital and capital surplus through a third-party allotment, an ¥80 million decrease in retained earnings due to the recognition of a net loss attributable to owners of the parent, and a ¥30 million decrease in the valuation difference on available-for-sale securities.」

    The valuation difference on available-for-sale securities decreased by ¥30 million, and the negative impact on net assets of fluctuations in the market prices of investment securities continued.
  11. FY2022-Q2WorsenedAnnual report

    「Other comprehensive income Valuation difference on available-for-sale securities △¥17.137 million」

    The valuation difference on available-for-sale securities decreased by ¥13.084 million in the cumulative second quarter, and the negative impact of fluctuations in the market prices of investment securities continued.
  12. FY2022-Q1WorsenedAnnual report

    「Other comprehensive income Valuation difference on available-for-sale securities △¥17.137 million」

    The valuation difference on available-for-sale securities decreased by ¥17.137 million in the first quarter, and the negative impact of fluctuations in the market prices of investment securities reappeared.
  13. FY2021Improved valuation differences, but a valuation loss on securities was recognizedAnnual report

    「The valuation difference on available-for-sale securities increased by ¥43.705 million, while an impairment loss of ¥3.853 million was recognized on securities during the consolidated fiscal year.」

    The valuation difference on available-for-sale securities shifted from a decrease of ¥87.742 million in the previous fiscal year to an increase of ¥43.705 million, while an impairment loss of ¥3.853 million was recognized on securities.
  14. FY2021-Q3MitigatedAnnual report

    「Net assets decreased by ¥214 million from the end of the previous consolidated fiscal year to ¥1,096 million. This was mainly attributable to a ¥242 million decrease in retained earnings due to the recognition of a net loss attributable to owners of the parent and a ¥28 million increase in the valuation difference on available-for-sale securities.」

    Although total net assets decreased, the valuation difference on available-for-sale securities increased by ¥28 million, indicating an improvement from the previous year's decrease in valuation differences caused by fluctuations in market prices.
  15. FY2021-Q2MitigatedAnnual report

    「Net assets decreased by ¥257 million from the end of the previous consolidated fiscal year to ¥1,053 million. This was mainly attributable to a ¥286 million decrease in retained earnings due to the recognition of a net loss attributable to owners of the parent and a ¥29 million increase in the valuation difference on available-for-sale securities.」

    Although total net assets decreased, the valuation difference on available-for-sale securities increased by ¥29 million, reducing the negative impact from the previous fiscal year of fluctuations in the market prices of investment securities.
  16. FY2020WorsenedAnnual report

    「Net assets decreased by ¥200 million from the end of the previous consolidated fiscal year to ¥1,310 million. This was mainly attributable to a ¥3 million increase in retained earnings due to the recognition of net income attributable to owners of the parent, dividends of ¥68 million, the acquisition of treasury shares for ¥47 million, and an ¥87 million decrease in the valuation difference on available-for-sale securities.」

    The valuation difference on available-for-sale securities decreased by ¥87 million, and fluctuations in the market prices of investment securities appeared as a decrease in net assets.
  17. FY2020-Q2MaterialisedAnnual report

    「Net assets decreased by ¥69 million from the end of the previous consolidated fiscal year to ¥1,442 million. This was mainly attributable to a ¥65 million increase in retained earnings due to the recognition of net income attributable to owners of the parent, dividends of ¥68 million, the acquisition of treasury shares for ¥47 million, and a ¥19 million decrease in the valuation difference on available-for-sale securities.」

    The valuation difference on available-for-sale securities related to investment securities decreased by ¥19 million, and the decrease in valuation differences on investment securities was recorded.
  18. FY2020-Q1MaterialisedAnnual report

    「This was attributable to a ¥21 million decrease in the valuation difference on available-for-sale securities.」

    The disclosed results included a ¥21 million decrease in the valuation difference on available-for-sale securities related to investment securities.
  19. FY2019First statedAnnual report

    「Investment securities consist primarily of shares held for investment purposes and are exposed to the risk of fluctuations in market prices.」

    The risk of fluctuations in market prices for shares held for investment purposes was disclosed as a financial instrument risk.
Moved together

"Timing mismatch in revenue recognition due to delays in delivering ordered products" moved the same way as this thread, in the same document, in 6 of its 19 moves.

654444★123456
  1. ★This thread
  2. 1Timing mismatch in revenue recognition due to delays in delivering ordered products6×
  3. 2Lengthening of the Accounts Receivable Collection Period and Deterioration in Operating Cash Flow Associated with the Introduction of Shopping Credit with a Collection Guarantee5×
  4. 3Sustainable Growth, Enhanced Corporate Value, and Building a Growth Cycle4×
  5. 4Strengthening Existing Businesses and Expanding the Earnings Base4×
  6. 5Building Customer Loyalty in the Beauty Business through More Efficient Promotions, Training and Store Development4×
  7. 6DSM Business Revenue Decline Due to Fewer Sales Representatives4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Yamano Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Market Price Risk on Investment Securities | YAMANO HOLDINGS CORPORATION (7571) | Komori